These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 35409489)
1. Multimorbidity Profiles and Infection Severity in COVID-19 Population Using Network Analysis in the Andalusian Health Population Database. Carmona-Pírez J; Ioakeim-Skoufa I; Gimeno-Miguel A; Poblador-Plou B; González-Rubio F; Muñoyerro-Muñiz D; Rodríguez-Herrera J; Goicoechea-Salazar JA; Prados-Torres A; Villegas-Portero R Int J Environ Res Public Health; 2022 Mar; 19(7):. PubMed ID: 35409489 [TBL] [Abstract][Full Text] [Related]
2. Patterns of multimorbidity and risk of severe SARS-CoV-2 infection: an observational study in the U.K. Chudasama YV; Zaccardi F; Gillies CL; Razieh C; Yates T; Kloecker DE; Rowlands AV; Davies MJ; Islam N; Seidu S; Forouhi NG; Khunti K BMC Infect Dis; 2021 Sep; 21(1):908. PubMed ID: 34481456 [TBL] [Abstract][Full Text] [Related]
3. Identifying multimorbidity profiles associated with COVID-19 severity in chronic patients using network analysis in the PRECOVID Study. Carmona-Pírez J; Gimeno-Miguel A; Bliek-Bueno K; Poblador-Plou B; Díez-Manglano J; Ioakeim-Skoufa I; González-Rubio F; Poncel-Falcó A; Prados-Torres A; Gimeno-Feliu LA; Sci Rep; 2022 Feb; 12(1):2831. PubMed ID: 35181720 [TBL] [Abstract][Full Text] [Related]
4. A Multimorbidity Analysis of Hospitalized Patients With COVID-19 in Northwest Italy: Longitudinal Study Using Evolutionary Machine Learning and Health Administrative Data. Benny D; Giacobini M; Catalano A; Costa G; Gnavi R; Ricceri F JMIR Public Health Surveill; 2024 Jul; 10():e52353. PubMed ID: 39024001 [TBL] [Abstract][Full Text] [Related]
5. Multimorbidity patterns in COVID-19 patients and their relationship with infection severity: MRisk-COVID study. Lleal M; Corral-Vazquez C; Baré M; Comet R; Herranz S; Baigorri F; Gimeno-Miguel A; Raurich M; Fortià C; Navarro M; Poblador-Plou B; Baré M PLoS One; 2023; 18(8):e0290969. PubMed ID: 37651465 [TBL] [Abstract][Full Text] [Related]
6. Associations Between Recently Diagnosed Conditions and Hospitalization due to COVID-19 in Patients Aged 50 Years and Older-A SHARE-Based Analysis. López-Bueno R; Torres-Castro R; Koyanagi A; Smith L; Soysal P; Calatayud J J Gerontol A Biol Sci Med Sci; 2022 Apr; 77(4):e111-e114. PubMed ID: 34251451 [TBL] [Abstract][Full Text] [Related]
7. Multimorbidity in middle-aged women and COVID-19: binary data clustering for unsupervised binning of rare multimorbidity features and predictive modeling. Benny D; Giacobini M; Costa G; Gnavi R; Ricceri F BMC Med Res Methodol; 2024 Apr; 24(1):95. PubMed ID: 38658821 [TBL] [Abstract][Full Text] [Related]
8. Chronic diseases associated with increased likelihood of hospitalization and mortality in 68,913 COVID-19 confirmed cases in Spain: A population-based cohort study. Gimeno-Miguel A; Bliek-Bueno K; Poblador-Plou B; Carmona-Pírez J; Poncel-Falcó A; González-Rubio F; Ioakeim-Skoufa I; Pico-Soler V; Aza-Pascual-Salcedo M; Prados-Torres A; Gimeno-Feliu LA; PLoS One; 2021; 16(11):e0259822. PubMed ID: 34767594 [TBL] [Abstract][Full Text] [Related]
9. At-risk population for COVID-19: multimorbidity characteristics of a European small Island state. Cuschieri S; Grech S Public Health; 2021 Mar; 192():33-36. PubMed ID: 33611169 [TBL] [Abstract][Full Text] [Related]
10. Multimorbidity patterns in patients with heart failure: an observational Spanish study based on electronic health records. Gimeno-Miguel A; Gracia Gutiérrez A; Poblador-Plou B; Coscollar-Santaliestra C; Pérez-Calvo JI; Divo MJ; Calderón-Larrañaga A; Prados-Torres A; Ruiz-Laiglesia FJ BMJ Open; 2019 Dec; 9(12):e033174. PubMed ID: 31874886 [TBL] [Abstract][Full Text] [Related]
11. Characteristics in Pediatric Patients with Coronavirus Disease 2019 in Korea. Seon JY; Jeon WH; Bae SC; Eun BL; Choung JT; Oh IH J Korean Med Sci; 2021 May; 36(20):e148. PubMed ID: 34032033 [TBL] [Abstract][Full Text] [Related]
12. Estimating and characterizing the burden of multimorbidity in the community: A comprehensive multistep analysis of two large nationwide representative surveys in France. Coste J; Valderas JM; Carcaillon-Bentata L PLoS Med; 2021 Apr; 18(4):e1003584. PubMed ID: 33901171 [TBL] [Abstract][Full Text] [Related]
13. Sex differences in clinical phenotype and transitions of care among individuals dying of COVID-19 in Italy. Raparelli V; Palmieri L; Canevelli M; Pricci F; Unim B; Lo Noce C; Villani ER; Rochon PA; Pilote L; Vanacore N; Onder G; Biol Sex Differ; 2020 Oct; 11(1):57. PubMed ID: 33066823 [TBL] [Abstract][Full Text] [Related]
14. Beyond Chronological Age: Frailty and Multimorbidity Predict In-Hospital Mortality in Patients With Coronavirus Disease 2019. Marengoni A; Zucchelli A; Vetrano DL; Armellini A; Botteri E; Nicosia F; Romanelli G; Beindorf EA; Giansiracusa P; Garrafa E; Ferrucci L; Fratiglioni L; Bernabei R; Onder G J Gerontol A Biol Sci Med Sci; 2021 Feb; 76(3):e38-e45. PubMed ID: 33216846 [TBL] [Abstract][Full Text] [Related]
15. Multimorbidity patterns of and use of health services by Swedish 85-year-olds: an exploratory study. Dong HJ; Wressle E; Marcusson J BMC Geriatr; 2013 Nov; 13():120. PubMed ID: 24195643 [TBL] [Abstract][Full Text] [Related]
16. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial. Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543 [TBL] [Abstract][Full Text] [Related]
17. Multimorbidity and population at risk for severe COVID-19 in the Brazilian Longitudinal Study of Aging. Nunes BP; Souza ASS; Nogueira J; Andrade FB; Thumé E; Teixeira DSDC; Lima-Costa MF; Facchini LA; Batista SR Cad Saude Publica; 2020; 36(12):e00129620. PubMed ID: 33237250 [TBL] [Abstract][Full Text] [Related]
18. Association of Comorbidities With Pneumonia and Death Among COVID-19 Patients in Mexico: A Nationwide Cross-sectional Study. Hernández-Vásquez A; Azañedo D; Vargas-Fernández R; Bendezu-Quispe G J Prev Med Public Health; 2020 Jul; 53(4):211-219. PubMed ID: 32752589 [TBL] [Abstract][Full Text] [Related]
19. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial. Akova M; Unal S Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629 [TBL] [Abstract][Full Text] [Related]